2023 Year in Review: The FTC and DOJ Ramp Up Oversight of Healthcare Dealmaking

Please join attorneys from Holland & Knight's Antitrust Team for a review of the key decisions and statements issued by the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) in 2023 that impact healthcare dealmaking.

Our attorneys will discuss the new Merger Guidelines recently issued by the FTC and DOJ, recent enforcement trends in the healthcare and private equity industries, updates to the Hart-Scott-Rodino (HSR) Act filing requirements, the emergence of state "Baby HSR" statutes applicable to the healthcare industry and what to expect in the year ahead.

We hope you can join us for this informative program.

Speakers:

David Kully | Partner, Washington, D.C.
Kenneth Racowski | Partner, Philadelphia
Bill Katz | Partner, Dallas

Continuing Legal Education (CLE)

Holland & Knight will apply for CLE credit based on attendee requests. Some programs may not be awarded CLE credits because of content or jurisdictional restrictions. CLE accreditation is sought after the completion of the program, and the approval process can be lengthy in some jurisdictions. Holland & Knight is an approved CLE provider in several jurisdictions, including California, Georgia, Illinois, New York, Pennsylvania and Texas. For New York attorneys, this program's format qualifies for CLE for transitional (newly admitted) and experienced attorneys.